About

About Mimetas MIMETAS is a global leader in disease modeling using Organ-on-a-Chip technologies. Founded in 2013 in Leiden, the Netherlands, MIMETAS strives to contribute to ground-breaking therapies with their screenable, physiologically relevant human disease models. By combining technological strengths and expertise, MIMETAS establishes strong drug development partnerships with and offers services to global pharmaceutical companies to develop innovative therapies to target untreatable diseases. MIMETAS was founded in 2013 in Leiden, the Netherlands, and has grown to a multinational company with operations in Asia, Europe, and the United States. To learn more about MIMETAS’ partnerships and services, visit